» Novo’s Ozempic Notches Approval for Kidney Disease, Widening Use




Novo Nordisk A/S’s blockbuster Ozempic won US approval to treat chronic kidney disease in patients who also have type 2 diabetes, further expanding the popular drug’s use.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *